Lingguizhugan decoction ameliorates cognitive impairment in AD-like mice by influencing the microbiome–gut–brain axis mediated by SCFAs
- 10 August 2024
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 133, 155942
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Dysbiosis and Alzheimer’s disease: role of probiotics, prebiotics and synbioticsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Impact of Alzheimer's association support and engagement in the AD/ADRD research community through the COVID‐19 pandemic and beyondAlzheimer's & Dementia, 2023
- Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomicsBiomedicine & Pharmacotherapy, 2022
- The role of short-chain fatty acids in central nervous system diseasesMolecular and Cellular Biochemistry, 2022
- Short chain fatty acids: Microbial metabolites for gut-brain axis signallingMolecular and Cellular Endocrinology, 2022
- Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's diseaseLife Sciences, 2021
- Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel diseasePharmacological Research, 2020
- Stable isotope labeling combined with liquid chromatography-tandem mass spectrometry for comprehensive analysis of short-chain fatty acidsAnalytica Chimica Acta, 2019
- Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouseBrain Research Bulletin, 2017
- 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1–40 brain-to-blood efflux and peripheral uptake transportNeuroscience, 2016